FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN

FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN was reported 548 times

FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OCHRONOSIS 5 0.0704
1 CHLOASMA 6 0.0129
2 DILATED PORES 1 0.0110
3 CHEMICAL INJURY 8 0.0098
4 SKIN HYPOPIGMENTATION 14 0.0079
5 ADMINISTRATION SITE IRRITATION 1 0.0071
6 DERMATOCHALASIS 1 0.0068
7 CONTACT LENS INTOLERANCE 1 0.0064
8 SKIN HYPERPIGMENTATION 48 0.0056
9 SKIN INFLAMMATION 1 0.0051
10 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
11 GALLBLADDER CHOLESTEROLOSIS 2 0.0044
12 INCORRECT PRODUCT STORAGE 43 0.0033
13 ALLERGY TO VACCINE 1 0.0032
14 TELANGIECTASIA 3 0.0031
15 APPLICATION SITE ACNE 1 0.0020
16 SKIN SENSITISATION 2 0.0019
17 SKIN DISCOMFORT 5 0.0019
18 PIGMENTATION DISORDER 11 0.0018
19 LIFE EXPECTANCY SHORTENED 1 0.0018
20 JUGULAR VEIN DISTENSION 1 0.0018
21 APPLICATION SITE DISCOLOURATION 7 0.0017
22 EYE BURNS 1 0.0017
23 SUPERIOR VENA CAVA SYNDROME 1 0.0017
24 SKIN FRAGILITY 4 0.0016
25 STASIS DERMATITIS 1 0.0015
26 INTENTIONAL UNDERDOSE 10 0.0014
27 DARK CIRCLES UNDER EYES 2 0.0014
28 LOCAL REACTION 1 0.0013
29 SKIN BURNING SENSATION 91 0.0013
30 EYELID EXFOLIATION 1 0.0013
31 LIP ERYTHEMA 1 0.0013
32 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
33 APPLICATION SITE EXFOLIATION 5 0.0012
34 SKIN INJURY 4 0.0012
35 LIP PRURITUS 1 0.0012
36 SKIN IRRITATION 51 0.0011
37 PAIN OF SKIN 29 0.0011
38 SKIN TEXTURE ABNORMAL 1 0.0010
39 RASH PAPULAR 21 0.0009
40 IRON OVERLOAD 1 0.0009
41 ROSACEA 4 0.0009
42 INCISION SITE PAIN 1 0.0009
43 SELF ESTEEM DECREASED 2 0.0008
44 EYELID SKIN DRYNESS 1 0.0008
45 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
46 SKIN EXFOLIATION 69 0.0008
47 REBOUND EFFECT 9 0.0008
48 SCAB 9 0.0008
49 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
50 ERYTHEMA 161 0.0008
51 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
52 LIP EXFOLIATION 1 0.0008
53 SKIN DEPIGMENTATION 1 0.0007
54 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
55 DISCHARGE 1 0.0007
56 SKIN HYPERTROPHY 2 0.0007
57 NEOPLASM SKIN 1 0.0006
58 SKIN TIGHTNESS 3 0.0006
59 PHARYNGEAL PARAESTHESIA 1 0.0006
60 DERMATITIS 13 0.0006
61 APPLICATION SITE DRYNESS 2 0.0006
62 PRODUCT COLOUR ISSUE 3 0.0006
63 HAIR GROWTH ABNORMAL 4 0.0006
64 SKIN SWELLING 5 0.0006
65 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
66 INTENTIONAL PRODUCT MISUSE 48 0.0005
67 LIP DISORDER 1 0.0005
68 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
69 SKIN WARM 3 0.0005
70 EARLY SATIETY 1 0.0005
71 GALLBLADDER INJURY 1 0.0005
72 APPLICATION SITE ERYTHEMA 13 0.0005
73 EAR HAEMORRHAGE 1 0.0005
74 SKIN INDURATION 1 0.0005
75 GASTRIC BYPASS 1 0.0005
76 SKIN DISCOLOURATION 21 0.0005
77 APPLICATION SITE URTICARIA 1 0.0004
78 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
79 PAPULE 3 0.0004
80 MEDICATION RESIDUE PRESENT 2 0.0004
81 DERMATITIS ALLERGIC 5 0.0004
82 CHEMICAL BURN OF SKIN 1 0.0004
83 DRY SKIN 52 0.0004
84 MEDICATION RESIDUE 1 0.0004
85 HERNIA REPAIR 1 0.0004
86 SKIN WRINKLING 1 0.0004
87 HYPERAESTHESIA 3 0.0004
88 PLEURITIC PAIN 1 0.0004
89 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
90 DERMATITIS CONTACT 4 0.0004
91 SCAR 6 0.0004
92 VISUAL DISTURBANCE 2 0.0003
93 LIP PAIN 1 0.0003
94 STRABISMUS 1 0.0003
95 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
96 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
97 KERATITIS 1 0.0003
98 FIBROSIS 1 0.0003
99 EYELIDS PRURITUS 1 0.0003
100 RASH MACULAR 11 0.0003
101 CHOLECYSTITIS CHRONIC 2 0.0003
102 PRODUCT USE ISSUE 54 0.0003
103 PRODUCT ODOUR ABNORMAL 3 0.0003
104 TYPE I HYPERSENSITIVITY 1 0.0003
105 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
106 SEBORRHOEA 1 0.0003
107 SUNBURN 2 0.0003
108 PRODUCT STORAGE ISSUE 1 0.0003
109 SKIN FISSURES 5 0.0003
110 WOUND SECRETION 1 0.0003
111 VENOUS THROMBOSIS 1 0.0003
112 SELF-MEDICATION 1 0.0002
113 DRUG EFFECT DECREASED 13 0.0002
114 ACCIDENTAL EXPOSURE 1 0.0002
115 CONDITION AGGRAVATED 73 0.0002
116 ABNORMAL SENSATION IN EYE 1 0.0002
117 ADVERSE REACTION 3 0.0002
118 PRODUCT STORAGE ERROR 19 0.0002
119 DEFORMITY 2 0.0002
120 BLISTER 12 0.0002
121 SKIN ABRASION 1 0.0002
122 SARCOIDOSIS 1 0.0002
123 EXPIRED DRUG ADMINISTERED 1 0.0002
124 INJECTION SITE INFLAMMATION 1 0.0002
125 APPLICATION SITE SWELLING 1 0.0002
126 STOMACH DISCOMFORT 1 0.0002
127 SKIN NECROSIS 1 0.0002
128 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
129 RASH ERYTHEMATOUS 9 0.0002
130 CHEILITIS 1 0.0002
131 CHOKING SENSATION 1 0.0002
132 SKIN ATROPHY 1 0.0002
133 DERMATITIS ACNEIFORM 1 0.0002
134 LARYNGEAL OEDEMA 1 0.0002
135 PRE-EXISTING CONDITION IMPROVED 1 0.0002
136 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
137 POOR QUALITY DRUG ADMINISTERED 1 0.0002
138 SWELLING FACE 10 0.0002
139 TENDON DISORDER 1 0.0002
140 INTENTIONAL OVERDOSE 9 0.0001
141 PRURITUS GENERALISED 3 0.0001
142 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
143 APPLICATION SITE PAIN 3 0.0001
144 SENSITIVE SKIN 1 0.0001
145 EYE SWELLING 5 0.0001
146 HYDRONEPHROSIS 1 0.0001
147 PRURITUS 51 0.0001
148 PAROSMIA 1 0.0001
149 APPLICATION SITE PRURITUS 3 0.0001
150 NASAL DISCOMFORT 1 0.0001
151 STENT PLACEMENT 1 0.0001
152 EXPIRED PRODUCT ADMINISTERED 4 0.0001
153 SKIN DISORDER 4 0.0001
154 EYE PRURITUS 4 0.0001
155 PRODUCT CONTAINER ISSUE 1 0.0001
156 BLOOD MAGNESIUM DECREASED 1 0.0001
157 GALLBLADDER DISORDER 2 0.0001
158 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
159 LIP DRY 1 0.0001
160 OPTIC NEURITIS 1 0.0001
161 ACNE 8 0.0001
162 BODY TEMPERATURE DECREASED 1 0.0001
163 HAEMATOCRIT DECREASED 2 0.0001
164 TOOTH ABSCESS 1 0.0001
165 EAR DISCOMFORT 1 0.0001
166 TRANSFUSION 1 0.0001
167 SCRATCH 1 0.0001
168 DRUG INEFFECTIVE 123 0.0001
169 HYPERSENSITIVITY 17 0.0001
170 RASH 38 0.0001
171 CHOLECYSTITIS 1 0.0001
172 THYROID CANCER 1 0.0001
173 PARAESTHESIA 13 0.0001
174 NO THERAPEUTIC RESPONSE 1 0.0001
175 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
176 APPLICATION SITE IRRITATION 1 0.0001
177 SKIN ULCER 2 0.0001
178 NODULE 1 0.0001
179 JOINT RANGE OF MOTION DECREASED 1 0.0001
180 EMOTIONAL DISTRESS 9 0.0001
181 RASH PRURITIC 4 0.0001
182 ACUTE HEPATIC FAILURE 1 0.0001
183 ORAL DISCOMFORT 1 0.0001
184 SKIN REACTION 1 0.0001
185 SKIN HAEMORRHAGE 1 0.0001
186 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
187 FEELING HOT 4 0.0001
188 ANKLE FRACTURE 1 0.0001
189 OCULAR HYPERAEMIA 3 0.0001
190 MUSCLE TIGHTNESS 1 0.0001
191 BACK DISORDER 1 0.0001
192 PHOTOSENSITIVITY REACTION 1 0.0001
193 DRY EYE 3 0.0001
194 LIP SWELLING 2 0.0001
195 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
196 LOCAL SWELLING 1 0.0001
197 AMENORRHOEA 1 0.0001
198 DERMATITIS ATOPIC 3 0.0001
199 SLEEP DISORDER 4 0.0001
200 DRUG ERUPTION 1 0.0001
201 UNDERDOSE 4 0.0001
202 MIDDLE INSOMNIA 1 0.0001
203 PHOTOPHOBIA 1 0.0001
204 SLEEP APNOEA SYNDROME 1 0.0001
205 PRESCRIBED UNDERDOSE 1 0.0001
206 PRODUCT PHYSICAL ISSUE 1 0.0000
207 HALLUCINATION, VISUAL 1 0.0000
208 OVERDOSE 10 0.0000
209 DEEP VEIN THROMBOSIS 3 0.0000
210 PRODUCT AVAILABILITY ISSUE 1 0.0000
211 NEPHROLITHIASIS 2 0.0000
212 MUSCLE TWITCHING 1 0.0000
213 BURNING SENSATION 3 0.0000
214 INJURY 3 0.0000
215 AGEUSIA 1 0.0000
216 ANHEDONIA 1 0.0000
217 DEPRESSED MOOD 2 0.0000
218 LIMB INJURY 1 0.0000
219 TREATMENT NONCOMPLIANCE 2 0.0000
220 SKIN LESION 1 0.0000
221 ABNORMAL DREAMS 1 0.0000
222 DIVERTICULITIS 1 0.0000
223 RED BLOOD CELL COUNT DECREASED 1 0.0000
224 EYE IRRITATION 2 0.0000
225 ASCITES 1 0.0000
226 BLOOD POTASSIUM DECREASED 1 0.0000
227 EMOTIONAL DISORDER 1 0.0000
228 LIMB DISCOMFORT 1 0.0000
229 EXPOSURE DURING PREGNANCY 2 0.0000
230 SWOLLEN TONGUE 1 0.0000
231 NIGHT SWEATS 1 0.0000
232 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
233 FUNGAL INFECTION 1 0.0000
234 URTICARIA 5 0.0000
235 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
236 NIGHTMARE 1 0.0000
237 LYMPHADENOPATHY 1 0.0000
238 PRODUCT ADHESION ISSUE 1 0.0000
239 CRYING 1 0.0000
240 HOT FLUSH 2 0.0000
241 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
242 PLASMA CELL MYELOMA 1 0.0000
243 JOINT SWELLING 3 0.0000
244 OSTEOARTHRITIS 1 0.0000
245 THROAT IRRITATION 1 0.0000
246 PRODUCT QUALITY ISSUE 3 0.0000
247 COGNITIVE DISORDER 1 0.0000
248 SWELLING 2 0.0000
249 ANXIETY 6 0.0000
250 FLUSHING 2 0.0000
251 FLUID RETENTION 1 0.0000
252 NERVOUSNESS 1 0.0000
253 ECZEMA 1 0.0000
254 MUSCULOSKELETAL PAIN 1 0.0000
255 OFF LABEL USE 16 0.0000
256 ANAPHYLACTIC REACTION 1 0.0000
257 NECK PAIN 1 0.0000
258 EYE PAIN 1 0.0000
259 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
260 CATARACT 1 0.0000
261 THERAPEUTIC RESPONSE DECREASED 1 0.0000
262 PLEURAL EFFUSION 1 0.0000
263 OEDEMA PERIPHERAL 2 0.0000
264 VERTIGO 1 0.0000
265 DISCOMFORT 1 0.0000
266 LOSS OF CONSCIOUSNESS 2 0.0000
267 BLOOD CREATININE INCREASED 1 0.0000
268 INFUSION RELATED REACTION 1 0.0000
269 FALL 5 0.0000
270 MOBILITY DECREASED 1 0.0000
271 EPISTAXIS 1 0.0000
272 BLOOD PRESSURE INCREASED 2 0.0000
273 DRY MOUTH 1 0.0000
274 DIZZINESS 6 0.0000
275 PAIN 7 0.0000
276 HEADACHE 7 0.0000
277 OROPHARYNGEAL PAIN 1 0.0000
278 DYSPHAGIA 1 0.0000
279 MIGRAINE 1 0.0000
280 PAIN IN EXTREMITY 3 0.0000
281 CHEST DISCOMFORT 1 0.0000
282 HAEMOGLOBIN DECREASED 1 0.0000
283 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
284 ABDOMINAL DISTENSION 1 0.0000
285 PLATELET COUNT DECREASED 1 0.0000
286 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
287 CONSTIPATION 2 0.0000
288 DEPRESSION 2 0.0000
289 ABDOMINAL PAIN 2 0.0000
290 PALPITATIONS 1 0.0000
291 DISEASE PROGRESSION 1 0.0000
292 FEELING ABNORMAL 2 0.0000
293 HYPERHIDROSIS 1 0.0000
294 PSORIASIS 1 0.0000
295 MEMORY IMPAIRMENT 1 0.0000
296 TREMOR 1 0.0000
297 ABDOMINAL DISCOMFORT 1 0.0000
298 CEREBROVASCULAR ACCIDENT 1 0.0000
299 MYALGIA 1 0.0000
300 URINARY TRACT INFECTION 1 0.0000
301 MUSCLE SPASMS 1 0.0000
302 NASOPHARYNGITIS 1 0.0000
303 DYSPNOEA 3 0.0000
304 ANAEMIA 1 0.0000
305 GAIT DISTURBANCE 1 0.0000
306 ALOPECIA 1 0.0000
307 NAUSEA 4 0.0000
308 SOMNOLENCE 1 0.0000
309 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
310 HYPERTENSION 1 0.0000
311 INCORRECT DOSE ADMINISTERED 1 0.0000
312 DECREASED APPETITE 1 0.0000
313 FATIGUE 3 0.0000
314 INSOMNIA 1 0.0000
315 WEIGHT DECREASED 1 0.0000
316 INJECTION SITE PAIN 1 0.0000
317 DIARRHOEA 2 0.0000
318 PYREXIA 1 0.0000
319 ARTHRALGIA 1 0.0000
320 MALAISE 1 0.0000
321 VOMITING 1 0.0000